AI Medical Service Inc. Completes First Regulatory Review an

- The endoscopic AI differentiates gastric lesions as neoplastic or non-neoplastic -TOKYO--(BUSINESS WIRE)--AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, is excited to announce the first instance of Singaporean regulatory review and device...

Related Keywords

Tokyo , Japan , Singapore , South Korea , Toshima Ku , Singaporean , Tada Tomohiro , Tomohiro Tada , National University Hospital Of Singapore , Singapore Health Sciences Authority , Tai Medical Service , School Of Medicine , Institute Of Gastroenterology Proctology , Department Of Surgical Oncology , Ai Medical Service Inc , University Of Tokyo , Development Of Endoscopic , University Of Tokyo Hospital , Health Sciences Authority , National University Hospital , Device Directive , Lives All Over , Service Inc , Tada Tomohiro The Institute , Visiting Lecturer , Surgical Oncology , Graduate School , Colorectal Surgery , Hareza Tower ,